U.S. Markets closed

iCo Therapeutics Inc. (ICO.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.040.00 (0.00%)
At close: 10:55AM EDT
People also watch
KNE.VDMA.VATE.VBTI.VEKG.V
Full screen
Previous Close0.04
Open0.05
Bid0.04 x 0
Ask0.05 x 0
Day's Range0.04 - 0.05
52 Week Range0.03 - 0.08
Volume13,000
Avg. Volume116,263
Market Cap3.38M
Beta3.62
PE Ratio (TTM)-3.33
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • What You Must Know About iCo Therapeutics Inc’s (TSXV:ICO) Risks
    Simply Wall St.14 days ago

    What You Must Know About iCo Therapeutics Inc’s (TSXV:ICO) Risks

    If you are a shareholder in iCo Therapeutics Inc’s (TSXV:ICO), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...

  • Associated Press28 days ago

    Ico Therapeutics posts 2Q loss

    On a per-share basis, the Vancouver, British Columbia-based company said it had a loss of less than 1 cent. In the final minutes of trading on Tuesday, the company's shares hit 4 cents. A year ago, they ...

  • Newsfile28 days ago

    iCo Therapeutics Announces Second Quarter 2017 Financial Results

    Vancouver, British Columbia--(Newsfile Corp. - August 29, 2017) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), today reported financial results for the quarter ended June 30, 2017. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS")."During the quarter, we reported the results of our preclinical, 14-day, GLP toxicology study with our novel Oral Amphotericin B (Oral Amp B) candidate. We were pleased ...